Search Results - "CAMARIS, C"

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma by Kondrashova, Olga, Topp, Monique, Nesic, Ksenija, Lieschke, Elizabeth, Ho, Gwo-Yaw, Harrell, Maria I., Zapparoli, Giada V., Hadley, Alison, Holian, Robert, Boehm, Emma, Heong, Valerie, Sanij, Elaine, Pearson, Richard B., Krais, John J., Johnson, Neil, McNally, Orla, Ananda, Sumitra, Alsop, Kathryn, Hutt, Karla J., Kaufmann, Scott H., Lin, Kevin K., Harding, Thomas C., Traficante, Nadia, deFazio, Anna, McNeish, Iain A., Bowtell, David D., Swisher, Elizabeth M., Dobrovic, Alexander, Wakefield, Matthew J., Scott, Clare L.

“…Accurately identifying patients with high-grade serous ovarian carcinoma (HGSOC) who respond to poly(ADP-ribose) polymerase inhibitor (PARPi) therapy is of…”
Get full text

Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer by Burdett, Nikki L., Willis, Madelynne O., Pandey, Ahwan, Twomey, Laura, Alaei, Sara, Bowtell, David D. L., Christie, Elizabeth L.

“…Whole genome duplication is frequently observed in cancer, and its prevalence in our prior analysis of end-stage, homologous recombination deficient high grade…”
Get full text

Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses by Cheasley, Dane, da Cunha Torres, Michelle, Salazar, Carolina, Xing, Zhongyue, Mes-Masson, Anne-Marie, Provencher, Diane M., Rahimi, Kurosh, Fasching, Peter A., Goodman, Marc T., Deen, Suha, Sieh, Weiva, Mateoiu, Constantina, Cook, Linda S., Le, Nhu D., Anglesio, Michael S., Chenevix-Trench, G., Traficante, N., Harrap, K., Sadkowsky, T., Mellon, A., Jones, M., Green, L., Ranieri, B., White, J., Bowes, L., Galletta, L., Giles, D., Hendley, J., Alsop, K., Young, C., Viduka, S., Glavinas, Lydia, Rutovitz, J., Glasgow, A., Bonaventura, T., Begbie, S., Baron-Hay, S., Nevell, D., Valmadre, S., Marsden, D., Beale, P., Beith, J., Carter, J., Dalrymple, C., Brand, A., Byth, K., Jaworski, R., Papadimos, D., Crandon, A., Cummings, M., Horwood, K., Perrin, L., Wyld, D., Davy, M., Oehler, M.K., Hall, C., Henderson, D., Miller, J., Blomfield, P., Rome, R., Grant, P., Laurie, R., Robbie, M., Manolitsas, T., McNealage, J., Susil, B., Sumithran, E., Phillips, K., Rischin, D., Fox, S., Loughrey, M., Billson, V., Neesham, D., Quinn, M., Blum, R., Leung, Y., Buck, M., Purdie, D., Ramus, Susan J., Scott, Clare L., Köbel, Martin, Gorringe, Kylie L., Allan, Prue E., Böhm, Maret, Christie, Michael, DeFazio, Anna, Fairweather, Nicole, Hadley, Alison M., Hendley, Joy, Ho, Gwo-Yaw, Huntsman, David G., Jobling, Tom W., Kennedy, Catherine J., Le Page, Cecile, Pyman, Jan, Rahimi, Kurosh, Samimi, Goli, Sharma, Ragwha, Antill, Yoland C., Gorringe, Kylie L.

“…TP53 mutations are implicated in the progression of mucinous borderline tumors (MBOT) to mucinous ovarian carcinomas (MOC). Optimized immunohistochemistry…”
Get full text

Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer by Burdett, Nikki L., Willis, Madelynne O., Pandey, Ahwan, Fereday, Sian, DeFazio, Anna, Bowtell, David D. L., Christie, Elizabeth L.

“…While the introduction of poly-(ADP)-ribose polymerase (PARP) inhibitors in homologous recombination DNA repair (HR) deficient high grade serous ovarian,…”
Get full text

BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance by Nesic, Ksenija, Krais, John J, Wang, Yifan, Vandenberg, Cassandra J, Patel, Pooja, Cai, Kathy Q, Kwan, Tanya, Lieschke, Elizabeth, Ho, Gwo-Yaw, Barker, Holly E, Bedo, Justin, Casadei, Silvia, Farrell, Andrew, Radke, Marc, Shield-Artin, Kristy, Penington, Jocelyn S, Geissler, Franziska, Kyran, Elizabeth, Betsch, Robert, Xu, Lijun, Zhang, Fan, Dobrovic, Alexander, Olesen, Inger, Kristeleit, Rebecca, Oza, Amit, McNeish, Iain, Ratnayake, Gayanie, Traficante, Nadia, DeFazio, Anna, Bowtell, David D L, Harding, Thomas C, Lin, Kevin, Swisher, Elizabeth M, Kondrashova, Olga, Scott, Clare L, Johnson, Neil, Wakefield, Matthew J

“…PARP inhibitor (PARPi) therapy has transformed outcomes for patients with homologous recombination DNA repair (HRR) deficient ovarian cancers, for example…”
Get full text

Malignant perivascular epithelioid cell tumor (PEComa) arising in the broad ligament by Fink, D, Marsden, D E, Edwards, L, Camaris, C, Hacker, N F

“…Malignant perivascular epithelioid cell tumor (PEComa) is an extremely rare mesenchymal neoplasm mostly composed of HMB-45-positive epithelioid cells with…”
Get more information

Correlates of placental infection with cytomegalovirus, parvovirus B19 or human herpes virus 7 by Chow, S.S.W., Craig, M.E., Jacques, C.F.H., Hall, B., Catteau, J., Munro, S.C., Scott, G.M., Camaris, C., McIver, C.J., Rawlinson, W.D.

“…Vertical transmission of viruses is an important cause of morbidity in the fetus and neonate. Placental viral infection indicates risk of vertical…”
Get full text

Prognostic gene expression signature for high-grade serous ovarian cancer by Intermaggio, M.P., Leong, H.S., Chen, S., Elatre, W., Gilks, B., Volchek, M., Wang, C., Mackenzie, R., George, J., Bowtell, D., Chenevix-Trench, G., Green, A., Gertig, D., Fereday, S., Moore, S., Hung, J., Harrap, K., Malt, M., Robertson, R., Maidens, J., Jayde, V., Mamers, P., Schmidt, T., Ball, C., Bilic, Sanela, Stuart-Harris, R., Clingan, P., Glasgow, A., Shannon, J., Young, B., Robertson, G., Carter, J., Dalrymple, C., Russell, P., Links, M., Jaworski, R., Crandon, A., Horwood, K., Obermair, A., Wyld, D., Davy, M., Dodd, T., Healy, T., Pittman, K., Henderson, D., Pierdes, J., Brown, B., Hyde, S., Healy, D., McNealage, J., Simpson, I., Fox, S., Lade, S., Loughrey, M., Neesham, D., Bell, R., Ng, L.F., Whiteman, D., Fereday, S., Steed, H., Koziak, J.M., Goranova, T., Silva De Silva, D., Ramón y Cajal, T., García-Donas, J., Rodriguez, G.C., Harris, H.R., Greene, C.S., Zelaya, R.A., Sinn, P., Menkiszak, J., Pearce, C.L., Rhenius, V., Piskorz, A.M., Sharma, R., Johnatty, S.E., Larson, M.C., Luk, H., Hernandez, B.Y., Thompson, P.J., Sherman, M.E., Bodelon, C., Lewsley, L.A., Banerjee, S.N., Stronach, E.A., Haluska, P., Ray-Coquard, I., Winterhoff, B., Slamon, D., Levine, D.A., Menon, U., Goodman, M.T., Schildkraut, J.M., Brown, R., Berchuck, A., Chenevix-Trench, G., deFazio, A., Beeghly-Fadiel, A., Fasching, P.A., Orsulic, S.

“…Median overall survival (OS) for women with high-grade serous ovarian cancer (HGSOC) is ∼4 years, yet survival varies widely between patients. There are no…”
Get full text

An audit of breast cancer pathology reporting in Australia in 1995 by KRICKER, A, ARMSTRONG, B, SMITH, C, BILOUS, M, CAMARIS, C, MAYER, A, PSARIANOS, T

“…To measure the quality of pathology reporting of breast cancer and establish a baseline against which future changes can be measured, we audited item…”
Get full text

Primary vulval ewing sarcoma/primitive neuroectodermal tumour in a 26-year-old lady by Noroozi, L., Weber, M., Barrett, W., Camaris, C.

Get full text

MyD88 and TLR4 Expression in Epithelial Ovarian Cancer by Winham, Stacey J., Traficante, Nadia, Tołoczko, Aleksandra, Tiezzi, Daniel G., Sinn, Peter, Rothstein, Joseph H., Paz-Ares, Luis, Oszurek, Oleg, Orsulic, Sandra, Nelson, Gregg, Menkiszak, Janusz, Longacre, Teri A., Li, Zheng, Lester, Jenny, Kennedy, Catherine J., Kalli, Kimberly R., Johnatty, Sharon E., Jensen, Allan, Hung, Jillian, Herpel, Esther, Hernandez, Brenda Y., Hartkopf, Andreas D., de Andrade, Jurandyr M., Chudecka-Głaz, Anita, Brucker, Sara Y., Bowtell, D., Webb, P., Gertig, D., Fereday, S., Moore, S., Harrap, K., Pandeya, N., Malt, M., Mellon, A., Robertson, R., Vanden Bergh, T., Brown, S., Green, L., Ferguson, K., Martyn, A., Ball, C., Bilic, Sanela, Stuart-Harris, R., Glasgow, A., Proietto, A., Braye, S., Shannon, J., Ferrier, A., Nevell, D., Valmadre, S., Young, B., Crouch, R., Robertson, G., Carter, J., Dalrymple, C., Houghton, R., Grygiel, J., Jaworski, R., Harnett, P., Wain, G., Papadimos, D., Crandon, A., Cummings, M., Horwood, K., Obermair, A., Davy, M., Dodd, T., Henderson, D., Pierdes, J., Brown, B., Allen, D., Grant, P., Robbie, M., Healy, D., Jobling, T., McNealage, J., Fox, S., Lade, S., Loughrey, M., O'Callaghan, N., Murray, W., Neesham, D., Bell, R., Ganju, V., Buck, M., Whiteman, D., Whittemore, Alice S., Steed, Helen, Kjaer, Susanne K., Kelemen, Linda E., Karlan, Beth Y., Huntsman, David G., Høgdall, Estrid, Gronwald, Jacek, Fasching, Peter A., Chang-Claude, Jenny, Campbell, Ian G., Pharoah, Paul D.P., Ramus, Susan J., Goode, Ellen L.

“…To evaluate myeloid differentiation primary response gene 88 (MyD88) and Toll-like receptor 4 (TLR4) expression in relation to clinical features of epithelial…”
Get full text

Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer by Merritt, Melissa A., Green, Adèle C., Nagle, Christina M., Webb, Penelope M.

“…Chronic inflammation has been proposed as the possible causal mechanism that explains the observed association between certain risk factors, such as the use of…”
Get full text

High-Throughput Amplicon-Based Copy Number Detection of 11 Genes in Formalin-Fixed Paraffin-Embedded Ovarian Tumour Samples by MLPA-Seq by Kondrashova, Olga, Love, Clare J, Lunke, Sebastian, Hsu, Arthur L, Waring, Paul M, Taylor, Graham R

“…Whilst next generation sequencing can report point mutations in fixed tissue tumour samples reliably, the accurate determination of copy number is more…”
Get full text

Consortium analysis of 7 candidate SNPs for ovarian cancer by Ramus, Susan J., Vierkant, Robert A., Johnatty, Sharon E., Pike, Malcolm C., Van Den Berg, David J., Wu, Anna H., Pearce, Celeste Leigh, Menon, Usha, Gentry‐Maharaj, Aleksandra, Gayther, Simon A., DiCioccio, Richard A., McGuire, Valerie, Whittemore, Alice S., Song, Honglin, Easton, Douglas F., Pharoah, Paul D.P., Garcia‐Closas, Montserrat, Chanock, Stephen, Lissowska, Jolanta, Brinton, Louise, Terry, Kathryn L., Cramer, Daniel W., Tworoger, Shelley S., Hankinson, Susan E., Berchuck, Andrew, Moorman, Patricia G., Schildkraut, Joellen M., Cunningham, Julie M., Liebow, Mark, Kjaer, Susanne Krüger, Hogdall, Estrid, Hogdall, Claus, Blaakaer, Jan, Ness, Roberta B., Moysich, Kirsten B., Edwards, Robert P., Carney, Michael E., Lurie, Galina, Goodman, Marc T., Wang‐Gohrke, Shan, Kropp, Silke, Chang‐Claude, Jenny, Webb, Penelope M., Chen, Xiaoqing, Beesley, Jonathan, Chenevix‐Trench, Georgia, Goode, Ellen L.

“…The Ovarian Cancer Association Consortium selected 7 candidate single nucleotide polymorphisms (SNPs), for which there is evidence from previous studies of an…”
Get full text

Recreational Physical Activity and Epithelial Ovarian Cancer: A Case-Control Study, Systematic Review, and Meta-analysis by OLSEN, Catherine M, BAIN, Christopher J, JORDAN, Susan J, NAGLE, Christina M, GREEN, Adèle C, WHITEMAN, David C, WEBB, Penelope M

“…It remains unclear whether physical activity is associated with epithelial ovarian cancer risk. We therefore examined the association between recreational…”
Get full text

Association Between Single-Nucleotide Polymorphisms in Hormone Metabolism and DNA Repair Genes and Epithelial Ovarian Cancer: Results from Two Australian Studies and an Additional Validation Set by BEESLEY, Jonathan, JORDAN, Susan J, GAYTHER, Simon A, PHAROAH, Paul D. P, WEBB, Penelope M, CHENEVIX-TRENCH, Georgia, SPURDLE, Amanda B, HONGLIN SONG, RAMUS, Susan J, KRUGER KJAER, Suzanne, HOGDALL, Estrid, DICIOCCIO, Richard A, MCGUIRE, Valerie, WHITTEMORE, Alice S

“…Although some high-risk ovarian cancer genes have been identified, it is likely that common low penetrance alleles exist that confer some increase in ovarian…”
Get full text

Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium by Pearce, C L, Near, A M, Van Den Berg, D J, Ramus, S J, Gentry-Maharaj, A, Menon, U, Gayther, S A, Anderson, A R, Edlund, C K, Wu, A H, Chen, X, Beesley, J, Webb, P M, Holt, S K, Chen, C, Doherty, J A, Rossing, M A, Whittemore, A S, McGuire, V, DiCioccio, R A, Goodman, M T, Lurie, G, Carney, M E, Wilkens, L R, Ness, R B, Moysich, K B, Edwards, R, Jennison, E, Kjaer, S K, Hogdall, E, Hogdall, C K, Goode, E L, Sellers, T A, Vierkant, R A, Cunningham, J C, Schildkraut, J M, Berchuck, A, Moorman, P G, Iversen, E S, Cramer, D W, Terry, K L, Vitonis, A F, Titus-Ernstoff, L, Song, H, Pharoah, P D P, Spurdle, A B, Anton-Culver, H, Ziogas, A, Brewster, W, Galitovskiy, V, Chenevix-Trench, G

“…The search for genetic variants associated with ovarian cancer risk has focused on pathways including sex steroid hormones, DNA repair, and cell cycle control…”
Get full text

Body size and risk of epithelial ovarian and related cancers: A population‐based case‐control study by Olsen, Catherine M., Nagle, Christina M., Whiteman, David C., Purdie, David M., Green, Adèle C., Webb, Penelope M.

“…Different subtypes of ovarian cancer appear to have different causes; however, the association between body mass index (BMI) and the different subtypes is…”
Get full text

Skewed X Chromosome Inactivation and Breast and Ovarian Cancer Status: Evidence for X-Linked Modifiers of BRCA1 by Lose, Felicity, Duffy, David L., Kay, Graham F., Kedda, Mary A., Spurdle, Amanda B.

“…Background X chromosome inactivation, which silences gene expression from one of the two X chromosomes in females, is usually random. Skewed X inactivation has…”
Get full text

Highly Sensitive Detection and Localization of Maternally Acquired Human Cytomegalovirus in Placental Tissue by In Situ Polymerase Chain Reaction by Trincado, Daniel E., Munro, Sian C., Camaris, Catherine, Rawlinson, William D.

“…BackgroundTransplacental transmission of human cytomegalovirus (CMV) can result in congenital malformations, although details on the mechanisms of transmission…”
Get full text